Skip to main content

AI drug discovery

By Trevor Dermody | 04:15 pm | March 15, 2024
The Israel-based company is the result of AION Labs' fifth startup challenge.
By Adam Ang | 01:11 am | February 26, 2024
Alongside generative AI, the large database has been foundational to the development of its latest AI-powered drug discovery system.   
By Nathan Eddy | 03:57 pm | December 06, 2023
The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.
By Nathan Eddy | 05:31 pm | November 30, 2023
The partners will leverage IBM’s foundation model technologies to help identify antibodies designed to target and neutralize various disease-causing agents or cells.
By Jessica Hagen | 04:18 pm | November 22, 2023
The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.
By Jessica Hagen | 02:15 pm | August 22, 2023
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.
By Jessica Hagen | 01:30 pm | July 13, 2023
The round brings the company's total raise to $93 million.
By Jessica Hagen | 03:15 pm | February 28, 2023
DenovAI will create an AI-powered platform to discover potential antibodies from scratch, then suggest which ones can be used as effective drugs.
By Adam Ang | 01:56 am | December 23, 2022
Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.
By Adam Ang | 07:06 am | November 25, 2022
Also, Edenlux is now providing AI-generated eye health reports in its mobile app.